Immigrant Ben Liu And TrialSpark Revolutionizing Clinical Trials
Ben Liu, an immigrant from Taiwan, is cofounder and CEO of TrialSpark. TrialSpark The story is as old as America.
Read moreBen Liu, an immigrant from Taiwan, is cofounder and CEO of TrialSpark. TrialSpark The story is as old as America.
Read moreThe investigational agent xanomeline-trospium (KarXT, Karuna Therapeutics), which combines a muscarinic receptor agonist with an anticholinergic agent, helps improve psychosis
Read moreRare gene variants are associated with a reduced risk for multiple types of liver disease, including cirrhosis, researchers say. People
Read morePeople with elevated levels of protein prostasin seem to have a higher risk of developing diabetes and dying from cancer,
Read moreLipoprotein(a) has long been thought to be a potential marker of aortic valve disease, and the population-based Rotterdam Study in
Read moreMany women with symptoms of menopause are turning to cannabis for help, researchers have found, despite a lack of evidence
Read moreAre Mini Robots Coming to Your Hospital? Super-small robot crabs could one day perform delicate surgical tasks, like repairing small
Read moreImagine being wheeled into the operating room where your surgical team awaits – the surgeon, the anesthesiologist, and … a
Read moreLOS ANGELES & NEW TAIPEI CITY, Taiwan–(BUSINESS WIRE)–Jul 31, 2022– SyneuRx™ International (TPEX:6575), a global biotech company focused on the
Read moreThe US Food and Drug Administration (FDA) has approved roflumilast 0.3% cream for the topical treatment of plaque psoriasis, “including
Read more